Form 4: Select Medical EVP Granted 50,000 Restricted Shares

John F. Duggan, Executive Vice President of Select Medical Holdings Corp., was granted 50,000 shares of restricted common stock, vesting in 2029.

Summary

• John F. Duggan, Executive Vice President of Select Medical Holdings Corp. (SEM), received a grant of 50,000 shares of common stock.
• The transaction date for this grant was October 28, 2025.
• The shares were granted at a price of $0, which is typical for restricted stock awards.
• Following this transaction, John F. Duggan beneficially owns 199,575 shares of common stock directly.
• The restricted stock is subject to certain exceptions and will vest in full on October 28, 2029, which is the fourth anniversary of the grant date.

Sentiment

Score: 6

Explanation: Slightly positive as it indicates executive retention and alignment of interests, which is generally viewed favorably by investors, though it's a routine compensation event.

Positives

• The grant of restricted stock aligns the Executive Vice President's long-term interests with those of shareholders, promoting retention and performance.
• Restricted stock grants are a common form of equity compensation, indicating ongoing commitment to executive incentives.

Future Outlook

The 50,000 restricted stock shares granted to Executive Vice President John F. Duggan are scheduled to vest in full on October 28, 2029, aligning his future compensation with the company's long-term performance.

Industry Context

This Form 4 filing reports a routine insider equity compensation event, common across various industries for executive retention and incentive alignment. It does not provide broader industry trend insights.

Stakeholder Impact

• Shareholders: The grant aligns executive incentives with shareholder value creation over the long term.
• Employees: Reflects standard executive compensation practices within the company.

Next Steps

• The restricted stock shares will vest on October 28, 2029.

Key Dates

Keywords

Select Medical Holdings Corp, SEM, Form 4, Insider Transaction, Restricted Stock, Equity Compensation, John F. Duggan, Executive Vice President, Stock Grant, Vesting